Latest Insider Transactions at Boston Scientific Corp (BSX)
This section provides a real-time view of insider transactions for Boston Scientific Corp (BSX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BOSTON SCIENTIFIC CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BOSTON SCIENTIFIC CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 09
2024
|
Yoshiaki Fujimori Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,901
+50.0%
|
-
|
|
May 09
2024
|
Susan E Morano Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,871
+19.36%
|
-
|
|
May 09
2024
|
Edward J Ludwig Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,901
+6.15%
|
-
|
|
May 09
2024
|
Jessica L Mega Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,901
+32.04%
|
-
|
|
May 09
2024
|
John E Sununu Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,901
+5.22%
|
-
|
|
May 09
2024
|
David S Wichmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,901
+6.84%
|
-
|
|
May 09
2024
|
Ellen M Zane Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,901
+5.64%
|
-
|
|
May 07
2024
|
Charles J Dockendorff Director |
SELL
Open market or private sale
|
Direct |
3,946
-100.0%
|
$284,112
$72.7 P/Share
|
|
May 02
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,017
-3.28%
|
$73,224
$72.03 P/Share
|
|
May 02
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,102
+6.34%
|
-
|
|
May 02
2024
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,917
-3.5%
|
$138,024
$72.03 P/Share
|
|
May 02
2024
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
4,203
+7.12%
|
-
|
|
May 01
2024
|
John Bradley Sorenson EVP, Global Operations |
SELL
Open market or private sale
|
Direct |
17,587
-25.78%
|
$1,248,677
$71.5 P/Share
|
|
May 01
2024
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
17,587
+20.49%
|
$298,979
$17.26 P/Share
|
|
May 01
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
6,983
-12.62%
|
$495,793
$71.47 P/Share
|
|
May 01
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,263
+3.74%
|
$85,260
$20.91 P/Share
|
|
Apr 26
2024
|
Edward J Ludwig Director |
SELL
Open market or private sale
|
Direct |
9,818
-19.18%
|
$716,714
$73.29 P/Share
|
|
Apr 26
2024
|
Edward J Ludwig Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,818
+16.09%
|
$166,906
$17.37 P/Share
|
|
Apr 01
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
6,983
-12.03%
|
$474,844
$68.42 P/Share
|
|
Apr 01
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,263
+3.57%
|
$85,260
$20.91 P/Share
|
|
Apr 01
2024
|
John Bradley Sorenson EVP, Global Operations |
SELL
Open market or private sale
|
Direct |
16,351
-24.41%
|
$1,128,219
$69.3 P/Share
|
|
Apr 01
2024
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,351
+19.62%
|
$261,616
$16.31 P/Share
|
|
Mar 18
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
14,506
-19.98%
|
$957,396
$66.45 P/Share
|
|
Mar 01
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
6,983
-11.49%
|
$460,878
$66.35 P/Share
|
|
Mar 01
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,263
+3.41%
|
$85,260
$20.91 P/Share
|
|
Feb 26
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
9,335
-24.39%
|
$625,445
$67.07 P/Share
|
|
Feb 26
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
4,185
+5.21%
|
$79,515
$19.99 P/Share
|
|
Feb 23
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
6,983
-11.0%
|
$460,878
$66.89 P/Share
|
|
Feb 23
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,263
+3.27%
|
$85,260
$20.91 P/Share
|
|
Feb 21
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
4,960
-6.39%
|
$327,360
$66.35 P/Share
|
|
Feb 20
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Discretionary transaction
|
Indirect |
67,974
-100.0%
|
$4,486,284
$66.22 P/Share
|
|
Feb 20
2024
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
13,662
-4.79%
|
$888,030
$65.86 P/Share
|
|
Feb 20
2024
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,662
+4.57%
|
$177,606
$13.08 P/Share
|
|
Feb 20
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Bona fide gift
|
Direct |
3,050
-4.9%
|
-
|
|
Feb 18
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
218
-0.67%
|
$14,170
$65.82 P/Share
|
|
Feb 18
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
741
+2.23%
|
-
|
|
Feb 18
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,829
-0.94%
|
$118,885
$65.82 P/Share
|
|
Feb 18
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,706
+1.87%
|
-
|
|
Feb 18
2024
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,644
-0.6%
|
$106,860
$65.82 P/Share
|
|
Feb 18
2024
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,706
+1.34%
|
-
|
|
Feb 18
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,052
-2.99%
|
$68,380
$65.82 P/Share
|
|
Feb 18
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,372
+6.32%
|
-
|
|
Feb 18
2024
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,233
-0.43%
|
$470,145
$65.82 P/Share
|
|
Feb 18
2024
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,307
+0.96%
|
-
|
|
Feb 18
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
822
-1.3%
|
$53,430
$65.82 P/Share
|
|
Feb 18
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,853
+2.85%
|
-
|
|
Feb 18
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
1,285
-1.63%
|
$83,525
$65.82 P/Share
|
|
Feb 18
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,817
+3.45%
|
-
|
|
Feb 18
2024
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
258
-0.67%
|
$16,770
$65.82 P/Share
|
|
Feb 18
2024
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
638
+1.64%
|
-
|